Skip to content

Acceptability and Feasibility of Implementing a Coordinated Hospital/Non-hospital Parenting Support and Prevention Program for Families of Infants at High Neurodevelopmental Risk After Neonatal Intensive Care Hospitalization

Acceptability and Feasibility of Implementing a Coordinated Hospital/Non-hospital Parenting Support and Prevention Program for Families of Infants at High Neurodevelopmental Risk After Neonatal Intensive Care Hospitalization

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05457569
Acronym
PRéPaR
Enrollment
88
Registered
2022-07-14
Start date
2023-01-09
Completion date
2025-11-30
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodevelopmental Motor Disorders

Brief summary

The PRéPaR project aims to construct, with the help of parents and early care providers, a support program for the families of infants at an increased risk for neurodevelopmental disorders, and to evaluate the acceptability and feasibility of such a program. This program aims to strengthen parenting skills, support infant development and improve the continuity of hospital/non-hospital care, including early identification of neurodevelopmental motor disorders and continuation of the support initiated during neonatal hospitalization.

Interventions

OTHERFocus group (FC) - WP1

3 group meetings for each group of parents: 1. Parents only 2. Parents and representatives of patient support groups 3. Parents and health professionals specialized in the care of these children at risk

OTHERChild Neurodevelopment Questionnaires - WP2

during the 4th month of corrected infant age

OTHEREvaluation of compliance for the acquired skills in terms of development support - WP2

during the 4th month of corrected infant age

OTHEREvaluation of physiotherapist satisfaction with the follow-up and the time spent at the consultation - WP2

at the end of the study

OTHER4 Focus Group (FC) - WP2

* Parents who accepted the follow-up * Parents who have partially completed the programme * Maternal and Child Protection & CAMSP professionals * Physiotherapists in a private practice

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

WP1: 1. For the group of parents of children with documented neurodevelopmental difficulties, their child must meet the following three conditions: * Be between 18 months and 48 months corrected age at the time of the first focus group * Have at least one risk factor putting them at high neurodevelopmental risk at birth: * Preterm infant ≤ 31 WG + 6 days * Birth weight less than 1500g * Child who has had a stroke or stages 2 or 3 hypoxic-ischaemic encephalopathy of the newborn according to the Sarnat classification * Central neurological lesion, diagnosed on brain imaging. * Present an abnormal, non-transient clinical state: diagnosis of cerebral palsy made or in progress (GMFCS 1 to 5), central neurological syndrome, diagnosed neurodevelopmental disorder. The parents must be able to participate in the 3 interviews (T1, T2 and T3). 2. For the group of infants at high neurodevelopmental risk at hospital discharge, their child must meet the following two conditions: * Be between 34 weeks of amenorrhea (i.e., 1.5 months premature) and 12 months of corrected age at the time of the first focus group, * Have at least one risk factor putting them at high neurodevelopmental risk at birth: * Preterm infant ≤ 31 WG + 6 days * Birth weight less than 1500g * Child who has had a stroke or stages 2 or 3 hypoxic-ischaemic encephalopathy of the newborn according to the Sarnat classification * Central neurological lesion, diagnosed on brain imaging. The parents must be able to participate in the 3 interviews (T1, T2 and T3). 3. Professionals and parent support groups: Physiotherapists in private practice, labor and delivery nurses of the Maternal and Child Protection, CAMSP (psychomotricians, psychologists) and doctors involved in the care of children at developmental risk in charge of the follow-up of children for whom the parents have agreed to participate in the study. These professionals must in turn have agreed to participate in the study. User representatives (SOS Préma, Le Neurogroup...) who have agreed to participate in the study. WP2: 1. Parents of children hospitalized in the neonatal services of the CHU Dijon who meet at least one of the following criteria: * Be between 34 weeks of amenorrhea (1.5 months premature) and 3 months of corrected age (3 months post-term) * Have at least one risk factor putting them at high neurodevelopmental risk at birth: * Child who has had a stroke or stages 2 or 3 hypoxic-ischaemic encephalopathy of the newborn according to the Sarnat classification * Central neurological lesion, diagnosed on brain imaging. 2. Professionals: Physiotherapists in private practice, labor and delievery nurses of the Maternal and Child Protection, CAMSP (psychomotricians, psychologists) and physicians involved in the care of children at developmental risk in charge of the follow-up of the children whose parents agreed to participate in the study. These professionals must in turn have agreed to participate in the study.

Exclusion criteria

* Parents who are physically or cognitively unable to participate in a group interview or who do not have a sufficient command of French. * Parents who are minors * Parents under legal protection * Parents of children with major orthopedic or traumatic disorders unrelated to the high risk of cerebral palsy.

Design outcomes

Primary

MeasureTime frameDescription
Typology, categorization and operationalization of parental needs and expectationsThrough WP1 completion an average of 18 monthsThese will be used to develop of the early education program
Typology of perceived subjective representations and description of barriers and levers to use with parents and professionalsthrough WP2 completion an average of 16 months

Countries

France

Contacts

Primary ContactSandrine JANDET CARON
sandrine.jandet@gmail.com0672089035

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026